W Glenn McCluggage Selected Research

Sarcoma (Soft Tissue Sarcoma)

1/2024	SMARCB1 (INI1) Deficient Tumours of the Uterine Cervix: Report of Two Cases, Including One Associated With an NTRK Fusion.
9/2022	Description of a Novel ERBB4 -rearranged Uterine Sarcoma.
1/2022	Cervical Small Cell Variant of Paraganglioma With Sarcomatous Transformation: Report of a Unique Case.
5/2021	p53 immunohistochemical analysis of fusion-positive uterine sarcomas.
1/2021	DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing.
1/2021	NTRK and other recently described kinase fusion positive uterine sarcomas: A review of a group of rare neoplasms.
1/2018	BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
6/2015	SMARCB1-deficient Vulvar Neoplasms: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 14 Cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W Glenn McCluggage Research Topics

Disease

83	Neoplasms (Cancer) 01/2024 - 01/2002
32	Carcinoma (Carcinomatosis) 02/2023 - 05/2004
20	Adenocarcinoma 08/2023 - 01/2002
13	Endometrial Neoplasms (Endometrial Cancer) 07/2022 - 05/2004
9	Endometrioid Carcinoma 11/2023 - 02/2005
9	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2002
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 05/2010
8	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 06/2015
6	Fibroma (Fibromatosis) 11/2023 - 07/2007
6	Neoplasm Metastasis (Metastasis) 08/2022 - 03/2010
5	Granulosa Cell Tumor 11/2023 - 02/2005
5	Carcinogenesis 02/2023 - 03/2006
5	Polyps 09/2021 - 05/2004
4	Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor) 08/2023 - 07/2007
4	Uterine Neoplasms (Uterine Cancer) 07/2023 - 05/2004
4	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 11/2022 - 08/2014
4	Hyperplasia 03/2022 - 02/2006
4	Adenosarcoma 01/2021 - 01/2002
4	Adenocarcinoma in Situ 09/2020 - 05/2009
4	Sertoli-Leydig Cell Tumor 05/2018 - 04/2007
4	Ovarian Epithelial Carcinoma 01/2018 - 04/2009
3	Leiomyoma (Uterine Fibroids) 07/2023 - 06/2011
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 02/2023 - 06/2004
3	Neuroendocrine Carcinoma 07/2022 - 04/2010
3	Teratoma (Teratoid Tumor) 09/2020 - 02/2005
3	Uterine Cervical Dysplasia 04/2015 - 01/2013
2	Carcinosarcoma 11/2023 - 01/2002
2	Osteosarcoma (Osteogenic Sarcoma) 08/2023 - 07/2017
2	Smooth Muscle Tumor 01/2023 - 06/2017
2	Endometrial Stromal Sarcoma 01/2023 - 05/2015
2	Vaginal Neoplasms (Cancer, Vaginal) 01/2023 - 01/2023
2	Embryonal Rhabdomyosarcoma 01/2021 - 10/2013
2	Small Cell Carcinoma 05/2019 - 11/2016
2	Disease Progression 01/2019 - 07/2016
2	Sertoli Cell Tumor 01/2019 - 07/2007
2	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 05/2018 - 02/2005
2	Lobular Carcinoma 01/2018 - 11/2010
2	Leiomyosarcoma 06/2017 - 06/2011

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2002
12	Calbindin 2IBA 07/2023 - 02/2005
10	Estrogen ReceptorsIBA 09/2022 - 01/2002
9	Cyclin D1IBA 12/2022 - 05/2015
8	Hormones (Hormone)IBA 11/2023 - 10/2009
8	Inhibins (Inhibin)IBA 07/2023 - 02/2005
8	MucinsIBA 12/2022 - 06/2009
8	VimentinIBA 10/2015 - 01/2002
7	RNA (Ribonucleic Acid)IBA 11/2023 - 06/2017
7	Progesterone Receptors (Progesterone Receptor)IBA 09/2022 - 03/2012
7	Biomarkers (Surrogate Marker)IBA 12/2020 - 09/2010
7	Mucin-1 (CA 15-3 Antigen)IBA 01/2019 - 02/2005
6	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 07/2004
5	SteroidsIBA 12/2023 - 05/2006
5	ChromograninsIBA 06/2023 - 04/2010
5	Keratins (Keratin)IBA 01/2009 - 02/2006
4	ChromatinIBA 01/2024 - 11/2016
4	Progestins (Progestagens)IBA 07/2023 - 06/2011
4	DesminIBA 01/2023 - 03/2013
4	CateninsIBA 12/2022 - 10/2015
4	MyogeninIBA 09/2021 - 03/2013
3	Sucrose (Saccharose)IBA 01/2024 - 11/2016
3	Transcription Factors (Transcription Factor)IBA 08/2023 - 01/2009
3	Carrier Proteins (Binding Protein)IBA 08/2023 - 06/2016
3	AntibodiesIBA 02/2023 - 05/2004
3	beta CateninIBA 12/2022 - 01/2018
3	Keratin-7 (Cytokeratin 7)IBA 01/2021 - 04/2007
3	Estrogens (Estrogen)FDA Link 01/2019 - 03/2013
3	PlatinumIBA 01/2019 - 12/2011
3	Cadherins (E-Cadherin)IBA 01/2019 - 11/2010
3	Indicators and Reagents (Reagents)IBA 03/2016 - 01/2013
3	Carcinoembryonic AntigenIBA 01/2013 - 01/2002
3	ElementsIBA 01/2013 - 01/2002
2	SMARCB1 ProteinIBA 01/2024 - 06/2015
2	SynaptophysinIBA 06/2023 - 09/2020
2	Messenger RNA (mRNA)IBA 02/2023 - 04/2009
2	Calmodulin-Binding Proteins (Caldesmon)IBA 01/2023 - 05/2004
2	LigandsIBA 05/2022 - 11/2021
2	Ribonucleases (Ribonuclease)IBA 09/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2021
2	CAM 5.2 antigenIBA 01/2021 - 02/2013
2	Immune Checkpoint InhibitorsIBA 12/2020 - 11/2020
2	ParaffinIBA 12/2020 - 10/2015
2	Melanins (Melanin)IBA 01/2019 - 10/2006
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2018 - 02/2005
2	Hepatocyte Nuclear FactorsIBA 01/2018 - 03/2012
2	Phenobarbital (Luminal)FDA Link 06/2016 - 02/2015
2	Diethylstilbestrol (Stilbestrol)FDA Link 05/2014 - 03/2012
2	ErbB Receptors (EGF Receptor)IBA 04/2014 - 11/2012
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2014 - 06/2007

Therapy/Procedure

15	Hysterectomy 09/2022 - 03/2006
9	Drug Therapy (Chemotherapy) 04/2021 - 01/2002
8	Radiotherapy 01/2023 - 01/2018
5	Therapeutics 03/2022 - 02/2011
5	Salpingo-oophorectomy 01/2022 - 08/2014
4	Ovariectomy (Oophorectomy) 01/2022 - 03/2015
4	Lymph Node Excision (Lymph Node Dissection) 09/2021 - 02/2012
3	Neoadjuvant Therapy 12/2018 - 08/2015
2	Salpingectomy 01/2022 - 01/2021
2	Curettage 01/2019 - 03/2006
2	Cystectomy 06/2017 - 03/2015
2	Adjuvant Chemotherapy 07/2016 - 07/2015